Tue, April 30, 2013
[ Tue, Apr 30th 2013 ] - Market Wire
IMRIS to hold first quarter 2013 results conference call and 2013 annual meeting of shareholders
[ Tue, Apr 30th 2013 ] - Market Wire
LifeSci Advisors Initiates Coverage of Brainstorm Cell Therapeutics
[ Tue, Apr 30th 2013 ] - Market Wire
Anatabloc Face Serum Launch Continues: Product Now Available at GNC
[ Tue, Apr 30th 2013 ] - Market Wire
RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise
[ Tue, Apr 30th 2013 ] - Market Wire
Calyx Provides Update on 2013 Resonance(R) Carinata Contracting Program
[ Tue, Apr 30th 2013 ] - Market Wire
Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration
[ Tue, Apr 30th 2013 ] - Market Wire
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
[ Tue, Apr 30th 2013 ] - Market Wire
Sinovac Files Annual Report on Form 20-F
[ Tue, Apr 30th 2013 ] - Market Wire
VentriPoint Receives Health Canada License for th .. RV(TM) Application for Non-Specific Heart Disease
[ Tue, Apr 30th 2013 ] - Market Wire
IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
[ Tue, Apr 30th 2013 ] - Market Wire
ProMetic and Sartorius Stedim Biotech ("SSB") Joi .. nkey Solution for Producing Plasma-Derived Therap
Mon, April 29, 2013
[ Mon, Apr 29th 2013 ] - Market Wire
HeartWare International Reports $49.2 Million In .. ;; 87% Increase From First Quarter Of 2012
[ Mon, Apr 29th 2013 ] - Market Wire
Extendicare Announces Dividend Reduction to C$0.04 per Share
[ Mon, Apr 29th 2013 ] - Market Wire
Galapagos Completes Private Placement by Issuance of 2,696,831 New Ordinary Shares
[ Mon, Apr 29th 2013 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against Intuitive Surgical, Inc
[ Mon, Apr 29th 2013 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bayer HealthCare LLC
[ Mon, Apr 29th 2013 ] - Market Wire
Peregrine Announces Completion of Patient Enrollm .. t in Breast Cancer Clinical Trial for Bavituximab
[ Mon, Apr 29th 2013 ] - Market Wire
UK Hospitals Order All Varian TrueBeam Radiothera .. Systems Offered Under Government Stimulus Program
[ Mon, Apr 29th 2013 ] - Market Wire
Galectin Inhibitors Reverse Liver Cirrhosis in Preclinical Studies
[ Mon, Apr 29th 2013 ] - Market Wire
Alimera Sciences Announces ILUVIEN Now Available In U.K.
[ Mon, Apr 29th 2013 ] - Market Wire
Comprehensive Care Corporation Names Colonel Ramo .. ez President of CompCare Pharmacy Solutions, Inc.
[ Mon, Apr 29th 2013 ] - Market Wire
Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
Sun, April 28, 2013
[ Sun, Apr 28th 2013 ] - Market Wire
Bayer to acquire Conceptus, Inc.
[ Sun, Apr 28th 2013 ] - Market Wire
Basilea reports presentation of new data on anti- .. ective drug candidates addressing drug resistance
Fri, April 26, 2013
[ Fri, Apr 26th 2013 ] - Market Wire
Sarepta Therapeutics to Announce First Quarter 20 .. ncial Results and Corporate Update on May 9, 2013
[ Fri, Apr 26th 2013 ] - Market Wire
Biologix Hair to Exhibit at 7th World Congress fo .. onal Investigative Dermatology Conference, Edinbu
[ Fri, Apr 26th 2013 ] - Market Wire
Additional U.S. Patents for Lead Cancer Drug Cand .. engthen Critical Outcome's Investment Proposition
[ Fri, Apr 26th 2013 ] - Market Wire
SpectraScience Rescheduling Workshops Due to High Demand
[ Fri, Apr 26th 2013 ] - Market Wire
Masimo Steps Up with March for Babiesa" to Fight for Healthier Newborns
[ Fri, Apr 26th 2013 ] - Market Wire
DIFICID (fidaxomicin) Tablets Approved in Australia
[ Fri, Apr 26th 2013 ] - Market Wire
Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
[ Fri, Apr 26th 2013 ] - Market Wire
Digirad Urges Stockholders to Vote the WHITE Proxy Card to Support Digirad's Director Nominees
[ Fri, Apr 26th 2013 ] - Market Wire
Ketchikan Medical Center Implements The SurgiCount Safety-Sponge System
[ Fri, Apr 26th 2013 ] - Market Wire
Simcere Pharmaceutical Group to Announce First Qu .. r 2013 Financial Results on Thursday, May 9, 2013
Thu, April 25, 2013
[ Thu, Apr 25th 2013 ] - Market Wire
NxStage Names Robert G. Funari Chairman Of The Board
[ Thu, Apr 25th 2013 ] - Market Wire
Star Scientific Announces Registration Approval f .. y, HFL Sport Science, for Anatabloc Dietary Suppl
[ Thu, Apr 25th 2013 ] - Market Wire
Leisureworld Closes Previously Announced Public O .. pts and Extendible Convertible Unsecured Subordin
[ Thu, Apr 25th 2013 ] - Market Wire
Vycor Adds Two Patents for Its New Spinal ViewSite(TM) Cervical Access System
[ Thu, Apr 25th 2013 ] - Market Wire
ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
[ Thu, Apr 25th 2013 ] - Market Wire
Ampio Pharmaceuticals Completes Enrollment in Run .. ING study of Ampion in Osteoarthritis of the Knee
[ Thu, Apr 25th 2013 ] - Market Wire
Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call
[ Thu, Apr 25th 2013 ] - Market Wire
VentriPoint Receives Request for Clarification to .. k) Submission for Pulmonary Arterial Hypertension
[ Thu, Apr 25th 2013 ] - Market Wire
Threshold Pharmaceuticals Announces Presentation .. at the 12th Annual Needham Healthcare Conference
[ Thu, Apr 25th 2013 ] - Market Wire
3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders
Wed, April 24, 2013
[ Wed, Apr 24th 2013 ] - Market Wire
Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign
[ Wed, Apr 24th 2013 ] - Market Wire
Life Care Medical Devices Ltd Announces CE Mark A .. ialization For Laparoscopic Surgery Access Device
[ Wed, Apr 24th 2013 ] - Market Wire
Biologix Hair Inc. Appoints Dr. Arthur G. Handal to Medical Advisory Board
[ Wed, Apr 24th 2013 ] - Market Wire
3SBio Inc. Enters Into Amendment to Merger Agreem .. ot;;Going Privatequot;; Transaction
[ Wed, Apr 24th 2013 ] - Market Wire
Gentiva Health Services Schedules First Quarter 2 .. rnings Call And Webcast For Thursday, May 9, 2013
[ Wed, Apr 24th 2013 ] - Market Wire
Paladin Labs Announces the Canadian Launch of AmnioSense(TM)
[ Wed, Apr 24th 2013 ] - Market Wire
Top-line Data Show AcelRx Pharmaceuticals' ARX-04 .. y Endpoint in Dose-Finding Phase 2 Clinical Trial
[ Wed, Apr 24th 2013 ] - Market Wire
STATS ChipPAC Appoints James A. Norling as Chairman
[ Wed, Apr 24th 2013 ] - Market Wire
Bullish $10 Million Bet Placed by CRO After CEL-SCI Acts to Accelerate Phase III Enrollment
[ Wed, Apr 24th 2013 ] - Market Wire
Omeros to Present at the 12th Annual Needham Healthcare Conference
Tue, April 23, 2013
[ Tue, Apr 23rd 2013 ] - Market Wire
AMRI and Ono Broaden SMARTSOURCINGa" Collaboration
[ Tue, Apr 23rd 2013 ] - Market Wire
Johnson amp;; Johnson to Host Pharmaceuticals Business Review
[ Tue, Apr 23rd 2013 ] - Market Wire
Celsion Corporation Provides Business Update
[ Tue, Apr 23rd 2013 ] - Market Wire
ISIS Pharmaceuticals Initiates a Clinical Study o .. IS-SMN Rx in Infants With Spinal Muscular Atrophy
[ Tue, Apr 23rd 2013 ] - Market Wire
Summit NW Selects Implant Sciences' QS-B220 Trace Detection System for Air Cargo Screening
[ Tue, Apr 23rd 2013 ] - Market Wire
Poorest U.S. States Rank Among Most Wasteful in Unnecessary Medication-Related Costs
[ Tue, Apr 23rd 2013 ] - Market Wire
Alchemia Announces Multi-Target Drug Discovery Co .. ation With AstraZeneca on VAST Discovery Platform
[ Tue, Apr 23rd 2013 ] - Market Wire
Ion Protona" de Life Technologies impulsa Stratified Medicine Scotland Innovation Centre
[ Tue, Apr 23rd 2013 ] - Market Wire
Ion Protona" da Life Technologies vai sustentar o Stratified Medicine Scotland Innovation Centre
[ Tue, Apr 23rd 2013 ] - Market Wire
Life Technologies' Ion Protona" to Power Stratified Medicine Scotland Innovation Centre
Mon, April 22, 2013
[ Mon, Apr 22nd 2013 ] - Market Wire
Galapagos starts Phase 2A study with GLPG0974 in ulcerative colitis
[ Mon, Apr 22nd 2013 ] - Market Wire
Lifshitz Law Firm Announces Investigation of Anar .. Life Technologies Corporation and National Finan
[ Mon, Apr 22nd 2013 ] - Market Wire
MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
[ Mon, Apr 22nd 2013 ] - Market Wire
IMRIS to exhibit novel state-of-the-art VISIUS iCT imaging solution at AANS
[ Mon, Apr 22nd 2013 ] - Market Wire
Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund
[ Mon, Apr 22nd 2013 ] - Market Wire
Cheaper Gas, Airfare, Profits on Way as Commoditi .. s? - Top Small Cap Stock Focus Ahead of the Bell:
[ Mon, Apr 22nd 2013 ] - Market Wire
VentriPoint Announces Closing of Offering
[ Mon, Apr 22nd 2013 ] - Market Wire
Implant Sciences' Quantum Sniffer Explosives and .. to Be Exhibited at 11th Annual Expo Seguridad Me
[ Mon, Apr 22nd 2013 ] - Market Wire
Novadaq to Release First Quarter 2013 Financial R .. sults On April 29, 2013-Conference Call to Follow
[ Mon, Apr 22nd 2013 ] - Market Wire
GSK and Theravance Announce Regulatory Submission for ANORO(TM) ELLIPTA(TM) (UMEC/VI) in Japan
Sun, April 21, 2013
[ Sun, Apr 21st 2013 ] - Market Wire
Galapagos discovers novel candidate drug to treat breast cancer
Fri, April 19, 2013
[ Fri, Apr 19th 2013 ] - Market Wire
Red Oak Partners Issues Open Letter to Digirad Co .. tion Shareholders About the Current Proxy Contest
[ Fri, Apr 19th 2013 ] - Market Wire
Ceregene Reports Data From Parkinson's Disease Phase 2b Study
[ Fri, Apr 19th 2013 ] - Market Wire
Novo Nordisk Unveils New U.S. Headquarters
[ Fri, Apr 19th 2013 ] - Market Wire
CML HealthCare Inc.'s Subsidiary, Hemostasis Refe .. rded Contract Extension with Isis Pharmaceuticals
[ Fri, Apr 19th 2013 ] - Market Wire
Ceapro Reports Full-Year 2012 Financial and Operating Results
[ Fri, Apr 19th 2013 ] - Market Wire
BioScrip Prices Underwritten Offering of Common Stock
[ Fri, Apr 19th 2013 ] - Market Wire
iTech Medical, Inc. Enters Into Letter of Intent .. tal Ventures Inc. in Respect of a Proposed Merger
[ Fri, Apr 19th 2013 ] - Market Wire
Varian Medical Systems and Paul Scherrer Institut .. ounce Collaboration on Motion Management for IMPT
[ Fri, Apr 19th 2013 ] - Market Wire
Interim PILLAR II Results Reported During SAGES
[ Fri, Apr 19th 2013 ] - Market Wire
Omeros to Present Additional OMS302 Clinical Data .. the Annual ASCRS and ASOA Symposium and Congress
Thu, April 18, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
La Jolla Pharmaceutical Company Receives Orphan Designation From FDA for LJPC-6417
[ Thu, Apr 18th 2013 ] - Market Wire
NW Bio Announces $10 Million Registered Direct Offering
[ Thu, Apr 18th 2013 ] - Market Wire
NW Bio Announces That Another Brain Cancer Patien .. rials Has Surpassed Ten-Year Cancer-Free Survival
[ Thu, Apr 18th 2013 ] - Market Wire
Unilife Develops Unifill Assurea" to Enhance Patient Self-Injection of Biologics
[ Thu, Apr 18th 2013 ] - Market Wire
UMeWorld New Trading Symbol "UMEWF" to Be Effective From April 18, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
BD Anuncia Aprovao FDA 510(k) e Lanamento Comercial do BD UltraSafe PLUSa" Passive Needle Guard
[ Thu, Apr 18th 2013 ] - Market Wire
Accuray Provides Clarification on Recently Initiated Voluntary Recalls
[ Thu, Apr 18th 2013 ] - Market Wire
Implant Sciences Showcases Its Explosive Trace De .. ection Equipment at Counter Terror Expo in London
[ Thu, Apr 18th 2013 ] - Market Wire
United Therapeutics Corporation To Announce First .. ts Before Market Open On Thursday, April 25, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
Un estudio publicado en European Radiology apoya el uso de la tomosntesis de mama de Hologic
Wed, April 17, 2013
[ Wed, Apr 17th 2013 ] - Market Wire
Cantel Medical To Present At Needham 12th Annual Healthcare Conference
[ Wed, Apr 17th 2013 ] - Market Wire
Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope
[ Wed, Apr 17th 2013 ] - Market Wire
Syneron Medical Appoints Co-Founder and Chairman .. Board Shimon Eckhouse to Chief Executive Officer
[ Wed, Apr 17th 2013 ] - Market Wire
Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program
[ Wed, Apr 17th 2013 ] - Market Wire
VentriPoint Receives CE Mark for Major Expansion of Its VMST Platform for Right Heart Analysis
[ Wed, Apr 17th 2013 ] - Market Wire
Lorus Therapeutics Signs Research and License Option Agreement with Elanco
[ Wed, Apr 17th 2013 ] - Market Wire
Quest Diagnostics to Acquire Lab-Related Clinical .. ations of Dignity Health in California and Nevada
[ Wed, Apr 17th 2013 ] - Market Wire
CML HealthCare Inc. Appoints Chief Medical Officer
[ Wed, Apr 17th 2013 ] - Market Wire
Almirall und Forest Laboratories geben positive R .. zur Kombination von Aclidinium und Formoterol be
[ Wed, Apr 17th 2013 ] - Market Wire
Almirall e Forest Laboratories annunciano i risul .. i fase III per la combinazione aclidinium e formo
Tue, April 16, 2013
[ Tue, Apr 16th 2013 ] - Market Wire
BioScrip Announces Proposed Refinancing of Existing Indebtedness
[ Tue, Apr 16th 2013 ] - Market Wire
BioScrip Announces Proposed Public Offering of Common Stock
[ Tue, Apr 16th 2013 ] - Market Wire
Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
[ Tue, Apr 16th 2013 ] - Market Wire
Critical Outcome Technologies Inc. Strengthens Investor Communications
[ Tue, Apr 16th 2013 ] - Market Wire
Cynosure To Host First-Quarter 2013 Financial Results Conference Call On April 30
[ Tue, Apr 16th 2013 ] - Market Wire
NW Bio's Phase III Trial With DCVax-L For Brain C .. dquot;; As A National Priority Trial In UK
[ Tue, Apr 16th 2013 ] - Market Wire
Lilly Announces Positive Results of Phase III Trials of Dulaglutide in Type 2 Diabetes
[ Tue, Apr 16th 2013 ] - Market Wire
Immunovaccine Receives Financial Contribution fro .. Provide Support Towards Clinical Studies in Comm
[ Tue, Apr 16th 2013 ] - Market Wire
Sequenom CMM Achieves Milestone Of 100,000 MaterniT21a" Plus Tests Processed
[ Tue, Apr 16th 2013 ] - Market Wire
DURECT Announces Submission of New Drug Application for POSIDURa" (SABER-Bupivacaine)
Mon, April 15, 2013
[ Mon, Apr 15th 2013 ] - Market Wire
Endo to Announce First Quarter 2013 Financial Results on May 7, 2013
[ Mon, Apr 15th 2013 ] - Market Wire
Star Scientific's Anatabloc Brand Ambassadors, Fr .. ples and John Isner, Shine at Weekend Tournaments
[ Mon, Apr 15th 2013 ] - Market Wire
Biologix Hair Inc. Retains Akerman Senterfitt;; Company to Pursue NYSE Market Listing
[ Mon, Apr 15th 2013 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation Of Acquisition By Thermo Fisher Scientific
[ Mon, Apr 15th 2013 ] - Market Wire
IsoRay on Display at the American Brachytherapy S .. eaturing Its Cesium-131 Cancer Fighting Portfolio
[ Mon, Apr 15th 2013 ] - Market Wire
Vycor Launches New Extension Arm for Its Patented ViewSite(TM) Brain Access System (VBAS)
[ Mon, Apr 15th 2013 ] - Market Wire
Med BioGene Announces Date of Annual and Special Meeting
[ Mon, Apr 15th 2013 ] - Market Wire
SeeThruEquity Initiates Coverage on Milestone Scientific
[ Mon, Apr 15th 2013 ] - Market Wire
Royalty Pharma Announces Firm Offer to Acquire Elan
[ Mon, Apr 15th 2013 ] - Market Wire
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States
Fri, April 12, 2013
[ Fri, Apr 12th 2013 ] - Market Wire
Quick-Med Engages Match Point Partners as Financial Advisor
[ Fri, Apr 12th 2013 ] - Market Wire
Gestion notify of 4.97% shareholding in Galapagos
[ Fri, Apr 12th 2013 ] - Market Wire
Boston Scientific Launches Precision Spectraa" Spinal Cord Stimulator System In The United States
[ Fri, Apr 12th 2013 ] - Market Wire
Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor
[ Fri, Apr 12th 2013 ] - Market Wire
Pre-Market Analysis on Life Technologies, Quest D .. Senior Living, Antares Pharma, and Optimer Pharma
[ Fri, Apr 12th 2013 ] - Market Wire
HCA Holdings, Tenet Healthcare, Health Management .. rsal Health Services Under StockCall's Microscope
[ Fri, Apr 12th 2013 ] - Market Wire
Today's Technical View on Sequenom, Peregrine Pharma, Inovio Pharma, and Onyx Pharma
[ Fri, Apr 12th 2013 ] - Market Wire
ProMetic Begins Trading on OTCQX(R)
Thu, April 11, 2013
[ Thu, Apr 11th 2013 ] - Market Wire
Regeneron to Report First Quarter 2013 Financial .. d Host Conference Call and Webcast on May 3, 2013
[ Thu, Apr 11th 2013 ] - Market Wire
MiMedx to Present at Regen Med Investor Day 2013
[ Thu, Apr 11th 2013 ] - Market Wire
Sunshine Heart, Inc. Prices $13.1 Million Public Offering of Common Shares
[ Thu, Apr 11th 2013 ] - Market Wire
Biologix Hair Inc. Announces Upward Revisions to Initially Reported Clinician Licensing Numbers
[ Thu, Apr 11th 2013 ] - Market Wire
Sarepta Therapeutics and University of Western Au .. rldwide Licensing Agreement for Exon-Skipping Pro
[ Thu, Apr 11th 2013 ] - Market Wire
BIOLASE Engages Porter, LeVay &;; Rose, Inc. for Investor Relations
[ Thu, Apr 11th 2013 ] - Market Wire
15 PM EDT
[ Thu, Apr 11th 2013 ] - Market Wire
AtheroNova Adds New Medical Advisor
[ Thu, Apr 11th 2013 ] - Market Wire
Boston Therapeutics Requests an IND Meeting With .. uce Postprandial Hyperglycemia in Type 2 Diabetes
[ Thu, Apr 11th 2013 ] - Market Wire
Pharmacyclics Triggers Fourth Milestone Payment f .. t of 5th Patient in Frontline Phase III CLL Study
Wed, April 10, 2013
[ Wed, Apr 10th 2013 ] - Market Wire
Sangamo BioSciences Announces Presentation At Regen Med Investor Day
[ Wed, Apr 10th 2013 ] - Market Wire
MEI Pharma's Mitochondrial Inhibitor Drug Candida .. ys Tumor Growth In Recurrent Ovarian Cancer Model
[ Wed, Apr 10th 2013 ] - Market Wire
Sirona Biochem Renews Corporate Development Contract with Ray Matthews and Associates
[ Wed, Apr 10th 2013 ] - Market Wire
Rotech Receives Approval of First Day Motions; .. 59; Approvals Ensure Operations Continue Normally
[ Wed, Apr 10th 2013 ] - Market Wire
Data Presented at AACR Annual Meeting Support Tar .. hanism and Potential of Peregrine's Bavituximab i
[ Wed, Apr 10th 2013 ] - Market Wire
USANA Receives More Than 20 Awards During First Quarter
[ Wed, Apr 10th 2013 ] - Market Wire
Extendicare Announces 2013 First Quarter Financia .. e, Conference Call and Annual Meeting Information
[ Wed, Apr 10th 2013 ] - Market Wire
Stocks Move Higher as Apple May Release New iPhone in Up to Three Different Sizes
[ Wed, Apr 10th 2013 ] - Market Wire
Aeterna Zentaris and Ergomed Sign Co-Development .. ring Agreement for AEZS-108 in Endometrial Cancer
[ Wed, Apr 10th 2013 ] - Market Wire
Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
Tue, April 9, 2013
[ Tue, Apr 09th 2013 ] - Market Wire
Canada's Largest Automated Hematology System is Now Live at CML HealthCare Inc.
[ Tue, Apr 09th 2013 ] - Market Wire
Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options
[ Tue, Apr 09th 2013 ] - Market Wire
Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
[ Tue, Apr 09th 2013 ] - Market Wire
POZEN to Host Analyst and Investor Update Webcast
[ Tue, Apr 09th 2013 ] - Market Wire
Critical Outcome Technologies Inc. Provides Important Update on AML Program
[ Tue, Apr 09th 2013 ] - Market Wire
CardioGuide System Enables Real-Time Navigation o .. t Ventricular Leads During Medtronic CRT Implants
[ Tue, Apr 09th 2013 ] - Market Wire
DiagnoCure's adoption of an advance notice policy
[ Tue, Apr 09th 2013 ] - Market Wire
Theratechnologies Board of Directors Appoints Former Merck Canada President
[ Tue, Apr 09th 2013 ] - Market Wire
30 a.m. ET
[ Tue, Apr 09th 2013 ] - Market Wire
Research shows that superbugs are killed by ACTICOATa" silver-coated antimicrobial dressings
Mon, April 8, 2013
[ Mon, Apr 08th 2013 ] - Market Wire
OriGene to Acquire SDIX's Life Science Business Assets
[ Mon, Apr 08th 2013 ] - Market Wire
DiaMedica Receives Phase I/II Clinical Trial Regu .. for DM-199 as a Potential Treatment for Diabetes
[ Mon, Apr 08th 2013 ] - Market Wire
CryoLife To Host Central Venous Pathology Summit
[ Mon, Apr 08th 2013 ] - Market Wire
French National Television Newscast Highlights En .. ring Hansen Medical's Magellan(TM) Robotic System
[ Mon, Apr 08th 2013 ] - Market Wire
Boston Therapeutics Featured in Four Publications
[ Mon, Apr 08th 2013 ] - Market Wire
Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products
[ Mon, Apr 08th 2013 ] - Market Wire
Theratechnologies Announces Termination of Agreement With Ferrer
[ Mon, Apr 08th 2013 ] - Market Wire
NewLink Genetics Presents Preclinical Data on New .. ay Inhibitor, NLG919, at AACR 2013 Annual Meeting
[ Mon, Apr 08th 2013 ] - Market Wire
Pharmacyclics Announces Third Breakthrough Therap .. utinib from the U.S. Food and Drug Administration
[ Mon, Apr 08th 2013 ] - Market Wire
SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting Firm
Sat, April 6, 2013
[ Sat, Apr 06th 2013 ] - Market Wire
GlaxoSmithKline and Liberty Property Trust/Synter .. k Environment with the Opening of Five Crescent D
Fri, April 5, 2013
[ Fri, Apr 05th 2013 ] - Market Wire
Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
[ Fri, Apr 05th 2013 ] - Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. n Their Investment in Incyte Corporation of Class
[ Fri, Apr 05th 2013 ] - Market Wire
East Tennessee Children's Hospital Installs Masim .. for Improved Oversight of Postoperative Patients
[ Fri, Apr 05th 2013 ] - Market Wire
TPI Targets Qionglai Facility (QLF) Construction Completion in Mid April
[ Fri, Apr 05th 2013 ] - Market Wire
GlaxoSmithKline and Liberty Property Trust/Synter .. k Environment with the Opening of Five Crescent D
[ Fri, Apr 05th 2013 ] - Market Wire
Uroplasty Announces CEO Resignation
[ Fri, Apr 05th 2013 ] - Market Wire
Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
[ Fri, Apr 05th 2013 ] - Market Wire
Trimel Pharmaceuticals Corporation Announces Upda .. Milestone Payment and Amendment to Loan Agreement
[ Fri, Apr 05th 2013 ] - Market Wire
MEI Pharma Announces $15.2 Million Registered Offering Of Common Stock
[ Fri, Apr 05th 2013 ] - Market Wire
EntreMed Announces Changes to Board of Directors and CEO Appointment
Thu, April 4, 2013
[ Thu, Apr 04th 2013 ] - Market Wire
Pharmagen Presents to North Carolina General Assembly at N.C. Bio's Legislative Breakfast
[ Thu, Apr 04th 2013 ] - Market Wire
Vista Partners Updates Coverage on Ohr Pharmaceutical, Inc.;; Price Target $3.50
[ Thu, Apr 04th 2013 ] - Market Wire
Syneron lanza la tecnologa exclusiva Sublative para cicatrices de acn
[ Thu, Apr 04th 2013 ] - Market Wire
BIOLASE Joins OSAP in Fight for Safe and Infection-Free Oral Healthcare
[ Thu, Apr 04th 2013 ] - Market Wire
Turning Atlanta into America's Next Silicon Valley
[ Thu, Apr 04th 2013 ] - Market Wire
CryoLife Receives FDA Clearance For Next Generation HeRO Device
[ Thu, Apr 04th 2013 ] - Market Wire
Array BioPharma Announces Updates on ARRY-520 Cli .. l Data at the 2013 International Myeloma Workshop
[ Thu, Apr 04th 2013 ] - Market Wire
Life Technologies Launches Oncomine Bioinformatics Solutions for Cancer Researchers
[ Thu, Apr 04th 2013 ] - Market Wire
CEL-SCI's Price Rebound Looks Strong
[ Thu, Apr 04th 2013 ] - Market Wire
VolitionRx Files Two Patent Applications
Wed, April 3, 2013
[ Wed, Apr 03rd 2013 ] - Market Wire
Brookdale Modifies Corporate Line of Credit
[ Wed, Apr 03rd 2013 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Affymax, Inc.
[ Wed, Apr 03rd 2013 ] - Market Wire
The Heart and Vascular Center Bad Bevensen Treats .. With Hansen Medical's Magellan(TM) Robotic System
[ Wed, Apr 03rd 2013 ] - Market Wire
Mylan Launches First Generic Version of Zovirax Ointment
[ Wed, Apr 03rd 2013 ] - Market Wire
Bernstein Liebhard LLP Announces That A Securitie .. tion Has Been Filed Against Star Scientific, Inc.
[ Wed, Apr 03rd 2013 ] - Market Wire
Hill-Rom Holdings, Inc. Hosts Fiscal 2013 Second Quarter Earnings Conference Call and Webcast

Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer


//health-fitness.news-articles.net/content/2013/ .. s-dr-paolo-baroldi-as-chief-medical-officer.html
Published in Health and Fitness on Wednesday, April 17th 2013 at 16:15 GMT by Market Wire   Print publication without navigation


Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer -- WASHINGTON, April 17, 2013 /PRNewswire/ --

WASHINGTON, April 17, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: [ VNDA ]), announced today that it has named Paolo Baroldi , M.D., Ph.D. as its Senior Vice President and Chief Medical Officer.

Dr. Baroldi has over 30 years of clinical development experience in many therapeutic areas, including neurology and psychiatry.  He has been working in the role of acting Chief Medical Officer with Vanda since October 1, 2012.

"We welcome Paolo to Vanda and look forward to his leadership in strengthening our clinical organization," said Mihael H. Polymeropoulos , M.D., President and Chief Executive Officer of Vanda.

Dr. Baroldi previously served as the Senior Vice President and Chief Medical Officer of Vanda from July 2006 through January 2009.  He has served in senior clinical development positions at Galileo Research, Supernus Pharmaceuticals, Chiesi Farmaceutici SpA, and Novartis AG.

Dr. Baroldi holds M.D. and Ph.D. degrees from the University of Milan, Italy and is a member of the board of directors of Galileo Research. 

ABOUT VANDA PHARMACEUTICALS INC.:

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit [ www.vandapharma.com ].

Company Contact

Jim Kelly
Senior Vice President  & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
[ jim.kelly@vandapharma.com ]

SOURCE Vanda Pharmaceuticals Inc.



RELATED LINKS
[ http://www.vandapharma.com ]

Publication Contributing Sources